Company: MVIS
Filing Date: 2025-04-18
Form Type: PRE 14A
Source: 0001641172-25-005410
Chunk: 20

Company: MICROVISION, INC.
Filing Date: 2025-04-18
Form: PRE 14A
Chunk 20
---
, capital markets transactions with institutional and other financial partners, and equity investments
in us by strategic partners, including customers. The availability of additional authorized shares of common stock would allow us to execute
any of these transactions in the future without additional shareholder approval, except as may be required in particular cases by our
Certificate of Incorporation, applicable law, or the rules of any stock exchange on which MicroVision securities may then be listed.

In approving the Share Capital Amendment, our Board considered many factors,
including the following:

| ● | the balance of our cash, cash equivalents and other liquid securities in light of expected near-term and 
 future cash needs;                                                                                       |

| ● | the amount of available authorized shares of our common stock and its current trading price; |

| ● | cash and cash equivalent balances, fundraising capacity, market capitalization, and trading prices of 
 peer companies and market competitors;                                                                |

| ● | the length of time of the typical development cycle, design win process, start of production, and product                                 
 implementation in the autonomy and mobility industries, particularly with regard to new products and market-changing solutions like ours; |

| ● | the potential need for investment throughout these cycles and the length of time to meaningful production 
 volume and revenue generation;                                                                            |

| ● | current trends and risks in the capital markets, uncertainty and weakness in the macroeconomic environment, 
 and instability and disruption in the geopolitical climate; and                                             |

| ● | the voting guidelines of our major institutional shareholders and the two largest proxy advisory firms, 
 namely Institutional Shareholder Services and Glass Lewis & Co.                                         |

The approval of the Share Capital Amendment is highly
important for our ongoing business. Successfully developing and commercializing perception software and lidar sensor solutions for our
target markets requires significant and disciplined investment of resources and the ability to sustain operations throughout the long
sales cycles, before meaningful volumes and revenue are realized.

| 15 |

If this proposal is not approved, we will be severely
limited in our ability to (i) raise capital that may be needed to fund further development and commercialization of our products, (ii)
develop key collaborations with capital markets participants, and (iii) engage in strategic partnerships or other arrangements that may
be needed to advance or accelerate our commercialization efforts, any of which could hamper our ability to successfully compete in our
target markets.

Our Board and management carefully considered the
number of shares needed for the increase sought in the Share Capital Amendment. The voting guidelines of our largest institutional shareholders
and the